Myelin-oligodendrocyte glycoprotein antibody-associated disease

R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …

Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria

B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …

Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

JY Hor, K Fujihara - Frontiers in Neurology, 2023 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an
inflammatory demyelinating disease of the central nervous system (CNS) with the presence …

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations

M Juryńczyk, A Jacob, K Fujihara, J Palace - Practical neurology, 2019 - pn.bmj.com
The field of central nervous system (CNS) inflammatory diseases has recently broadened to
include a new condition associated with pathogenic serum antibodies against myelin …

MOG antibody disease: a review of MOG antibody seropositive neuromyelitis optica spectrum disorder

R Narayan, A Simpson, K Fritsche, S Salama… - Multiple sclerosis and …, 2018 - Elsevier
MOG antibody disease is an autoimmune disease of the central nervous system associated
with a serological antibody against MOG, myelin oligodendrocyte glycoprotein. MOG is a …

Myelin oligodendrocyte glycoprotein antibodies in neurological disease

M Reindl, P Waters - Nature Reviews Neurology, 2019 - nature.com
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …

Neurological update: MOG antibody disease

R Wynford-Thomas, A Jacob, V Tomassini - Journal of neurology, 2019 - Springer
Myelin oligodendrocyte glycoprotein (MOG) antibody disease (MOG-AD) is now recognised
as a nosological entity with specific clinical and paraclinical features to aid early diagnosis …

Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica

JR Ciotti, NS Eby, GF Wu, RT Naismith… - Multiple Sclerosis and …, 2020 - Elsevier
Background Antibodies to myelin oligodendrocyte glycoprotein (MOG) are associated with a
CNS inflammatory disorder distinct from multiple sclerosis (MS) and aquaporin-4 antibody …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management

E Sechi, L Cacciaguerra, JJ Chen, S Mariotto… - Frontiers in …, 2022 - frontiersin.org
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

A Al-Ani, JJ Chen, F Costello - Journal of Neurology, 2023 - Springer
New diagnostic criteria for myelin oligodendrocyte glycoprotein antibody-associated disease
(MOGAD) have recently been proposed, distinguishing this syndrome from other …